111 related articles for article (PubMed ID: 37721089)
41. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.
Li Y; Zhang H; Kosturakis AK; Cassidy RM; Zhang H; Kennamer-Chapman RM; Jawad AB; Colomand CM; Harrison DS; Dougherty PM
Brain Behav Immun; 2015 Oct; 49():255-66. PubMed ID: 26065826
[TBL] [Abstract][Full Text] [Related]
42. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
43. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
44. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
Koyanagi M; Imai S; Iwamitsu Y; Matsumoto M; Saigo M; Moriya A; Ogihara T; Nakazato Y; Yonezawa A; Nakagawa S; Nakagawa T; Matsubara K
Neuropharmacology; 2021 May; 188():108514. PubMed ID: 33684416
[TBL] [Abstract][Full Text] [Related]
45. Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.
Copland JA; Marlow LA; Kurakata S; Fujiwara K; Wong AK; Kreinest PA; Williams SF; Haugen BR; Klopper JP; Smallridge RC
Oncogene; 2006 Apr; 25(16):2304-17. PubMed ID: 16331265
[TBL] [Abstract][Full Text] [Related]
46. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
Berger JP; Petro AE; Macnaul KL; Kelly LJ; Zhang BB; Richards K; Elbrecht A; Johnson BA; Zhou G; Doebber TW; Biswas C; Parikh M; Sharma N; Tanen MR; Thompson GM; Ventre J; Adams AD; Mosley R; Surwit RS; Moller DE
Mol Endocrinol; 2003 Apr; 17(4):662-76. PubMed ID: 12554792
[TBL] [Abstract][Full Text] [Related]
47. Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice.
Basu A; Yang JY; Tsirukis VE; Loiacono A; Koch G; Khwaja IA; Krishnamurthy M; Fazio N; White E; Jha A; Shah S; Takmil C; Bagdas D; Demirer A; Master A; Natke E; Honkanen R; Huang L; Rigas B
Front Neurosci; 2023; 17():1240372. PubMed ID: 38347876
[TBL] [Abstract][Full Text] [Related]
48. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
49. Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.
Lee SM; Muratalla J; Diaz-Ruiz A; Remon-Ruiz P; McCann M; Liew CW; Kineman RD; Cordoba-Chacon J
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34417811
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study.
Park SJ; Yim GW; Paik H; Lee N; Lee S; Lee M; Kim HS
J Gynecol Oncol; 2021 Sep; 32(5):e73. PubMed ID: 34132071
[TBL] [Abstract][Full Text] [Related]
51. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
[TBL] [Abstract][Full Text] [Related]
52. Honokiol: a non-adipogenic PPARγ agonist from nature.
Atanasov AG; Wang JN; Gu SP; Bu J; Kramer MP; Baumgartner L; Fakhrudin N; Ladurner A; Malainer C; Vuorinen A; Noha SM; Schwaiger S; Rollinger JM; Schuster D; Stuppner H; Dirsch VM; Heiss EH
Biochim Biophys Acta; 2013 Oct; 1830(10):4813-9. PubMed ID: 23811337
[TBL] [Abstract][Full Text] [Related]
53. Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
Chen YF; Chen LH; Yeh YM; Wu PY; Chen YF; Chang LY; Chang JY; Shen MR
Sci Rep; 2017 Mar; 7():45366. PubMed ID: 28349969
[TBL] [Abstract][Full Text] [Related]
54. Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.
Chen CS; Smith EML; Stringer KA; Henry NL; Hertz DL
Breast Cancer Res Treat; 2022 Aug; 194(3):551-560. PubMed ID: 35760975
[TBL] [Abstract][Full Text] [Related]
55. Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy.
Kalynovska N; Diallo M; Sotakova-Kasparova D; Palecek J
J Cell Mol Med; 2020 Jul; 24(14):7949-7958. PubMed ID: 32485058
[TBL] [Abstract][Full Text] [Related]
56. Probing for chemotherapy-induced peripheral neuropathy in live dorsal root ganglion neurons with atomic force microscopy.
Au NP; Fang Y; Xi N; Lai KW; Ma CH
Nanomedicine; 2014 Aug; 10(6):1323-33. PubMed ID: 24632247
[TBL] [Abstract][Full Text] [Related]
57. Preventive hypothermia as a neuroprotective strategy for paclitaxel-induced peripheral neuropathy.
Beh ST; Kuo YM; Chang WW; Wilder-Smith E; Tsao CH; Tsai CH; Chen LT; Liao LD
Pain; 2019 Jul; 160(7):1505-1521. PubMed ID: 30839425
[TBL] [Abstract][Full Text] [Related]
58. Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Cetinkaya-Fisgin A; Zhu J; Luan X; Kim JS; Oh B; Brayton C; Alt J; Rais R; Slusher B; Höke A
Neurotherapeutics; 2021 Jul; 18(3):2061-2072. PubMed ID: 34291431
[TBL] [Abstract][Full Text] [Related]
59. Peroxisome proliferator-activated receptor gamma (PPARγ) agonist fails to overcome trans-10, cis-12 conjugated linoleic acid (CLA) inhibition of milk fat in dairy sheep.
Sandri EC; Camêra M; Sandri EM; Harvatine KJ; De Oliveira DE
Animal; 2018 Jul; 12(7):1405-1412. PubMed ID: 29122042
[TBL] [Abstract][Full Text] [Related]
60. Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Cook BM; Reifert J; Wozniak KM; Slusher BS; Littlefield BA; Wilson L; Jordan MA; Feinstein SC
Neurotox Res; 2016 Feb; 29(2):299-313. PubMed ID: 26659667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
